InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Discover the complete record of transactions filed by Murphy Kimberly M, Director. Director active across 1 companies, notably Clarus Therapeutics Holdings, Inc.. Cumulatively, 3 reports have been published. The latest transaction was disclosed on 7 June 2022 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
Declarations3 total
01,922 shares0
Common Stock
SEC:0000899243-22-021760:0·
03,844 shares0
Common Stock
SEC:0000899243-21-048202·
03,844 shares0
Common Stock
SEC:0000899243-21-048202:0·
3 of 3 declarations
About Murphy Kimberly M
Kimberly M. Murphy is a Board Member of Clarus Therapeutics Holdings, Inc. In this role, she participates in the governance and strategy of the company. Her experience in the healthcare sector is a valuable asset to the board.
